Latest Asx News

Empire Resources Limited has completed the issuance of 1 million shares under the second tranche of its placement, following shareholder approval at the recent extraordinary meeting. This move strengthens the company’s capital base as it pushes forward with its gold and copper projects in Western Australia.

Betashares Capital Ltd has announced the Distribution Reinvestment Plan (DRP) issue prices for its Australian High Interest Cash ETF and Cash Plus Active ETF for the March 2026 distribution period. Investors must submit DRP elections by 7 April 2026, with unit issuance scheduled for 13 April.

Lithium Energy Limited has completed its initial drilling campaign at the Sandy Creek Prospect within Queensland’s Capricorn Gold-Copper Belt, with assay results expected in late May 2026. The company’s next steps hinge on these findings amid a region rich in historic mineralisation.

Healthscope has paid all rent due through April 2026 for hospitals owned by HealthCo Healthcare & Wellness REIT, while alternative operators submit plans to take over hospital operations.

Cauldron Energy Limited has clarified that its recent share price jump is driven by easing geopolitical tensions and a buoyant uranium market, with no undisclosed material information influencing trading.

PEXA Group has dismissed any undisclosed information behind its recent share price drop, attributing market moves to a preliminary IPART pricing consultation paper.

Acrow Limited has reported record new hire contracts and a robust sales pipeline, confirming FY26 guidance and issuing optimistic initial guidance for FY27 revenue and earnings.

CVC Limited has addressed ASX concerns over a delayed Appendix 3Y filing related to director John Leaver’s interest change, attributing the delay to administrative oversight while affirming existing compliance policies.

Dome Gold Mines Ltd launches a $3 million convertible note offering to fund key developments in Fiji, including the Sigatoka Feasibility Study and expanded exploration for copper, gold, and silver.

Lumos Diagnostics has secured its largest-ever order for FebriDx® following FDA clearance, signalling a major expansion in the US market opportunity.

Advanced Innergy Holdings Ltd has responded to ASX inquiries denying any media leak regarding its proposed $0.40 cash bid for Matrix Composites & Engineering, reaffirming its commitment to strict disclosure policies.

Arovella Therapeutics has demonstrated that its novel CLDN18.2-targeting CAR incorporated into iNKT cells effectively eliminates pancreatic and gastric cancer cells in vitro, with IL-12-TM armouring enhancing potency and durability.